Subcutaneous injection · Short course protocol (5–10 days annually)
Half-life
Short plasma half-life; effects via downstream gene regulatory interactions in thymic tissue
Most studied use
Immune restoration · Thymic support · Longevity stacking with Thymalin and Epithalon
Regulatory status
Not FDA-approved · Research chemical · Used in Russian clinical practice
Human evidence
Limited — used in 12-year longevity cohort alongside Thymalin; individual attribution not isolatable
Preclinical evidence
Moderate — IL-2 restoration, T-cell maturation effects in cell and animal models from Khavinson group
EDUCATIONAL TOOL — NOT MEDICAL ADVICE
What is Vilon?
Vilon is a synthetic dipeptide — just two amino acids: lysine-glutamic acid (Lys-Glu, abbreviated KE). Developed by Professor Vladimir Khavinson at the Saint Petersburg Institute of Bioregulation and Gerontology, it is the Cytogen (synthetic sequence) form of the thymus bioregulator system. Where Thymalin is the full natural thymic extract (Cytomax), Vilon is the isolated active dipeptide.
The thymus is ground zero for immune aging. It involutes progressively from your 20s — the thymic tissue that produces T-cells is steadily replaced by fat and connective tissue. By age 50, most people have lost the majority of functional thymic tissue. This thymic involution is one of the most reproducible features of biological aging, correlating directly with declining immune competence, reduced resistance to infection, and increased cancer risk.
Vilon's proposed role is to send a direct signal — at the chromatin level — that counteracts this decline. Khavinson's group characterizes it as a gene expression regulator for thymic tissue, capable of promoting T-cell maturation and interleukin production in aged immune systems.
How it works
Chromatin Interaction, Not Receptor Binding
Like all Khavinson Cytogens, Vilon is hypothesized to work epigenetically. The peptide penetrates cell nuclei and interacts with DNA-histone complexes, influencing gene expression in thymic tissue specifically. This differs from most peptides, which bind surface receptors. The chromatin interaction model predicts tissue-specific effects — which is what the available evidence suggests.
Interleukin Modulation
Cell studies show Vilon modulates interleukin-2 (IL-2) production — a key T-cell growth factor — and upregulates interferon-gamma in lymphocytes. These are the cytokines most directly involved in T-cell proliferation and activation. In aged animals with reduced IL-2 production, Vilon restored IL-2 levels toward younger profiles.
T-Cell Maturation
Khavinson's group reported that Vilon promotes differentiation and maturation of T-lymphocytes — supporting the conversion of immature thymocytes to functional mature T-cells. This is the core mechanism proposed for its immune-restorative effects.
What the research shows
NOTE — PRIMARILY FROM KHAVINSON GROUP · SAME SINGLE-GROUP LIMITATION AS EPITHALON AND PINEALON
STUDYAnnals of the New York Academy of Sciences · 2003
12-Year Longevity Cohort with Thymic Bioregulators
Khavinson VK, Morozov VG
Elderly subjects receiving annual courses of thymic bioregulators (including Vilon and Thymalin) alongside pineal peptides showed approximately 2-fold lower mortality over 12 years vs. untreated controls. Immune parameters improved and functional status was maintained.
STUDYBulletin of Experimental Biology and Medicine · 2002
Vilon (KE) Restores IL-2 Production in Aging Lymphocytes
Khavinson VK et al.
Vilon (KE) restored IL-2 production in lymphocytes from aged subjects toward levels seen in younger controls. T-cell proliferative response to mitogens was also improved. Effects were most pronounced in subjects with the most compromised baseline immune function.
Thymic Peptide Effects on T-Cell Subsets in Aged Animals
Morozov VG et al.
Short thymic peptides including KE modulated CD4+/CD8+ T-cell ratios in aged animals toward younger immune profiles. The dipeptide sequence was sufficient to drive T-cell subset normalization independent of the full Thymalin extract.
Vilon is moderately popular in longevity biohacker circles, primarily as the injectable Cytogen counterpart to Thymalin. It frequently appears in the same stack — a Thymalin course followed by Vilon maintenance, or both run simultaneously. Reports focus on subjective improvements in immune resilience (fewer infections, faster recovery), energy, and general wellbeing over 3–6 month windows.
Because Vilon is a dipeptide (smaller than most Cytogens), some researchers suggest superior tissue penetration. This is theoretical — not established in controlled studies. The practical observation is that it is well-tolerated with a low side-effect profile consistent with other Khavinson short peptides.
WHAT THE RESEARCH SHOWS
✓KNOWN
✓Vilon is a synthetic dipeptide (Lys-Glu) derived from thymic tissue research — the Cytogen form of the thymus bioregulator
✓Cell studies show IL-2 modulation and T-cell proliferation effects
✓Used in 12-year human cohort alongside Thymalin and pineal peptides — 2-fold survival benefit observed in the combination
✓Well-tolerated in available clinical data with no serious adverse events reported
✓Distinct from Thymalin: Vilon is the isolated synthetic dipeptide; Thymalin is the full natural extract
?Optimal dosing protocol — 5-day annual course is the most cited, but no dose-finding trials exist
?Whether the chromatin interaction mechanism is the actual mode of action or a working hypothesis
?Long-term safety profile beyond available Russian clinical observation data
?Whether effects observed in elderly subjects apply to younger populations using it preventively
RECONSTITUTION CALCULATOR
EDUCATIONAL TOOL — NOT MEDICAL ADVICE · VERIFY WITH YOUR CLINICIAN
AI COACH PREVIEW
I'm 45 and want to start a thymic bioregulator protocol for immune restoration and longevity. Should I use Vilon, Thymalin, or both — and how do I structure the cycle?
For thymic restoration at your age, the classic Khavinson approach is to anchor with Thymalin (the full Cytomax extract) for your main annual course — typically 5–10 mg/day for 5 days — and then use Vilon (KE) for shorter maintenance windows in between. The reasoning: Thymalin provides the broad spectrum of thymic peptides, while Vilon's dipeptide structure allows for more frequent low-dose signaling without the full course commitment. Many protocols run Thymalin once or twice yearly, then Vilon as a 3-day course every 4–6 weeks as maintenance. Your baseline immune markers matter here — if your CD4/CD8 ratio and NK cell activity are already good, the maintenance frequency can be lower. Pair with Epithalon for the full foundational longevity stack.
CONTINUE IN THE APP
Open PepperLedger to ask the Coach about Vilon dosing and stacking →
Free to join. The Coach understands the full Khavinson bioregulator system and can help you build a protocol around your specific goals.
Free to join · No credit card · 23-day Pro trial included